“Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Proactive Versus Reactive Strategies” (2023) Translational Medicine & Therapeutics Journal, 2(1), pp. 28–36. doi:10.5281/zenodo.22649043.